Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation

Scientific Reports(2021)10.1038/s41598-021-87228-5Source: DataRank Database

Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.875. It has been cited 22 times, with 9 citing works in its 1-hop citation network.

N/A

0.875DataRank · unranked

Scored on demand from live citation data

Open Access22 citations · 9 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 2.40)OA: goldTopics (93)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 54%Citation Network 46%

Base Score Contribution

0.470

From this paper's citation signal

Citation Network Contribution

0.405

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 9 citers.

Porcine cancer models for clinical translation
Nature reviews. Cancer202216 citations11 referencesContributes 0.258
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions
World Journal of Gastroenterology202317 citations54 referencesContributes 0.054
Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig
Disease Models & Mechanisms202219 citations58 referencesContributes 0.052
Swine models for translational oncological research: an evolving landscape and regulatory considerations
Mammalian Genome202114 citations90 referencesContributes 0.030
Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig
bioRxiv (Cold Spring Harbor Laboratory)20205 citations67 referencesContributes 0.027

Authors (18)

Kenneth N. Aycock ORCID,Margaret A. Nagai-Singer ORCID,Sheryl Coutermarsh‐Ott ORCID,Melvin F. Lorenzo ORCID,Jessica M. Gannon ORCID

Live enrichment

PubMed:33828203 PMC:PMC8027815 OpenAlex:https://openalex.org/W3150572449

National Institutes of Health

Grant: R01CA213423

National Institutes of Health

Grant: R21OD027062

National Institutes of Health

Grant: R21EB028429

NCI NIH HHS

Grant: P01 CA207206

NCI NIH HHS

Grant: R01 CA240476

National Institutes of Health

Grant: 1R21EB028429-01

Employing Novel Porcine Models of Orthotopic Pancreatic Cancer to Evaluate Histotripsy Based Tumor Ablation Strategies

National Institutes of Health

Grant: 5R01CA213423-02

High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment

National Institutes of Health

Grant: 1R21OD027062-01

Germ cell preservation of immunodeficient pigs utilizing embryo complementation approach

National Institutes of Health

Grant: 3P01CA207206-05S1

Rapid Electrical Impedance Spectroscopy for Detection of High-Frequency Irreversible Electroporation Ablation Growth in a Rodent Glioma Model

Focused Ultrasound Foundation

Virginia Biosciences Health Research Corporation

Virginia Tech Institute for Critical Technology and Applied Sciences Center for Engineered Health

Virginia Maryland College of Veterinary Medicine

FWCI

2.40

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-021-87228-5.pdf

publisherhttps://www.nature.com/articles/s41598-021-87228-5.pdf

publisherhttps://www.nature.com/articles/s41598-021-87228-5

journalhttps://doi.org/10.1038/s41598-021-87228-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33828203

Fields of Study

Microbial Inactivation MethodsMicrofluidic and Bio-sensing Technologies3D Printing in Biomedical Research0301 basic medicine03 medical and health sciences0302 clinical medicineAdenocarcinomaAnimalsCRISPR-Cas SystemsCell Line, TumorDNA-Binding ProteinsElectric ConductivityElectroporationFemaleGene Knockout TechniquesHumansImmunocompromised HostInterleukin Receptor Common gamma SubunitMaleMicePancreatic NeoplasmsProof of Concept StudySwineTranslational Research, BiomedicalXenograft Model Antitumor Assays

MeSH Terms

Proof of Concept StudyAdenocarcinomaAnimalsDNA-Binding ProteinsElectric ConductivityFemaleHumansMalePancreatic NeoplasmsSwineImmunocompromised HostElectroporationXenograft Model Antitumor AssaysCell Line, TumorMiceInterleukin Receptor Common gamma SubunitGene Knockout TechniquesTranslational Research, BiomedicalCRISPR-Cas Systems

Keywords

Pancreatic cancerIrreversible electroporationAdenocarcinomaMedicineCancer researchElectroporationCRISPRCancerXenotransplantationHistopathologyImmune systemEx vivoPathologyBiologyIn vivoTransplantationImmunologyInternal medicineBiotechnologysafetyMalemiceSwineSciencetumor xenograftschemotherapyablationProof of Concept StudyArticleTranslational Research, BiomedicalGene Knockout TechniquesImmunocompromised HostCell Line, TumorAnimalsHumansmouseQgemcitabineRElectric ConductivitypigsXenograft Model Antitumor AssaysDNA-Binding ProteinsPancreatic NeoplasmsFemaleCRISPR-Cas SystemsimmunodeficiencyfeasibilityInterleukin Receptor Common gamma Subunit

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Good health and well-being